Infectoscab

Permethrin, the active ingredient in Infectoscab, is a synthetic pyrethroid presented as a topical formulation for cutaneous use. It is classified as an antiparasitic scabicide and works by targeting the nervous system of the scabies mite. GNH USA supplies Infectoscab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infectoscab is a scabicide that acts on ectoparasitic infestations of the skin. - Scabies: eliminates Sarcoptes scabiei mites and resolves associated itching and rash. - Crusted scabies: reduces high mite burden in severe, hyperinfested cases. - Secondary bacterial infection prevention: helps prevent infection by removing the primary cause of skin irritation.

Topical application of Permethrin may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Mild itching or burning at the application site. - Redness or erythema of the skin. - Dryness or flaking of treated skin. - Minor rash or hives. - Tingling sensation. - Temporary worsening of itching.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling, difficulty breathing. - Extensive skin irritation or dermatitis. - Secondary infection of the skin. - Systemic toxicity presenting as dizziness or nausea. - Unusual swelling or blistering of the skin. - Persistent or worsening rash despite treatment.

Infectoscab should be used according to a qualified health‑care professional’s instructions. - Contraindication: Do not apply to individuals with known hypersensitivity to permethrin or other pyrethroids. - Age restriction: Use only in patients for whom the prescriber deems it appropriate, typically older children and adults. - Application area: Avoid contact with eyes, mucous membranes, and open wounds. - Pregnancy and lactation: Discuss risks with a health‑care provider before use. - Storage: Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Permethrin’s topical use has limited systemic drug interaction potential.

Major Interactions (Avoid): - Concurrent use of other topical scabicides containing organophosphates, which may increase neurotoxic risk. - Application over large areas combined with systemic neurotoxic agents.

Moderate Interactions (Monitor Closely): - Use with other skin irritants or sensitizers may exacerbate local reactions. - Co‑administration with topical corticosteroids may mask irritation signs. - Overlapping use with other antiparasitic creams may increase skin absorption. - Use with occlusive dressings can enhance systemic exposure. - Combination with other pyrethroid products should be avoided to prevent cumulative toxicity.